
KYTX vs AGEN
$KYTX vs $AGEN head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
KYTX vs AGEN: trend, levels and the market
One year to 2026-11-20, against the S&P 500 (+3.2%). Split-adjusted daily closes.
- ·KYTX is the weaker of the two on trend, below both its 50- and 200-day averages, while AGEN has held above one of them.
- ·Only AGEN beat the market over the past year, by 36%, while KYTX trailed the S&P 500 at +3.2% by 46.3%.
- ·AGEN has support 19.2% below at $4.77; KYTX has no tested support within 35% under its price.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
KYTX vs AGEN: the quick read
- ·AGEN is the larger company by market cap ($270M vs $269M).
- ·AGEN has the smaller float (45.2M vs 63.2M), which tends to mean sharper, more volatile moves.
- ·Both are biological products, (no diagnostic substances) names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Both stay busy on our scanner, 119 and 119 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 0% of each other on market cap, which makes the rest of this table the interesting part.
Objective differences only. Not investment advice.
Watching KYTX or AGEN? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing KYTX and AGEN on TheDesperateTrader.
- Is KYTX or AGEN the better stock?
- "Better" depends on your goal, and these two are not alike. AGEN is the larger company by market cap ($270M vs $269M). AGEN has the smaller float (45.2M vs 63.2M), which tends to mean sharper, more volatile moves. Both are biological products, (no diagnostic substances) names, so this is a like-for-like comparison and sector news tends to move them together. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between KYTX and AGEN?
- The differences that matter: they are similar in size ($269M vs $270M); they trade at very different share prices ($4.18 vs $5.90); KYTX sits at 0% of its 52-week range against 42% for AGEN. Everything above is measured from the latest completed session and SEC filings.
- Which of KYTX and AGEN is more active right now?
- Right now KYTX is at about 1.6x its normal volume and AGEN is at about 0.9x, so KYTX is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is KYTX or AGEN in the stronger trend?
- KYTX is below its 50-day average of $5.90 and below its 200-day average of $7.80; AGEN is below its 50-day average of $7.26 and above its 200-day average of $5.19. AGEN leads 5 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading KYTX or AGEN? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore KYTX and AGEN comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.